December 3, 2013

As the role of the changes in the epigenome is becoming more and more revealed there are a growing number of scientific papers reporting epigenetic/epigenomic studies. Malicious epigenomic alterations can be the reason behind widespread social problems like different types of cancers (eg. breast cancer), as well as rare diseases like ICF (Immunodeficiency, Centromeric region instability, Facial anomalies) syndrome, the like of which often not interest the medical industry therefore the diagnostic/therapeutic products are underdeveloped or non-existent at all. Such chromatin diseases (Rett syndrome, ATRX syndrome, FSHD, ICF syndrome) are the subject of the DisChrom project (FP7 project under the grant agreement PTN-GA-2009-238242) in which we participate.

Download the poster


  • Symposium of the Young Scientist Association
    Vienna, Austria
    May 28-May 29, 2024
  • ESHG 2024
    Berlin, Germany
    Jun 1-Jun 4, 2024
  • CLEPIC 2024
    Warsaw, Poland
    Jun 5-Jun 7, 2024
  • EACR 2024
    Rotterdam, Netherlands
    Jun 10-Jun 13, 2024
  • Chromatin meets South 2024
    Marseille, France
    Jun 13-Jun 14, 2024
 See all events


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics